Avecho to present at the ASX SMIDcaps Conference

Sep 22, 2026 at 7:01 PM EDT · Issued by Avecho Biotechnology Limited via ASX

Filed with ASX · Sep 22, 2026 at 7:01 PM EDT · 11 pages · English

On 6ix: 6ix.com/news/avecho-to-present-at-the-asx-smidcaps-conference

Release

Avecho Biotechnology Limited | ASX: AVE | ACN: 056 482 403 | ABN: 32 056 482 403 Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168avecho.com.au ASX Announcement23 September 2026Avecho to present at the ASX SMIDcaps ConferenceMelbourne, Australia, 23 September 2026: Avecho...

Avecho Biotechnology Limited on 6ix

In the deck

Avecho Biotechnology — ASX SMIDcaps Conference 202611 slidesSep 23, 2026

Earlier from Avecho Biotechnology

Avecho enters final stage of Phase III insomnia trialAug 30
Appendix 4D and Half-year Financial ReportAug 25
Avecho strengthens BD capability with senior appointmentAug 23
Small Holding Share Sale Facility CompletionAug 11
Japanese patent granted for CBD capsuleAug 2

Later from Avecho Biotechnology

Avecho to present at the Canaccord Drug and Device ConfeOct 12
Response to ASX Price QueryOct 21
Change of Chief Financial OfficerOct 27
September 2026 Quarterly Activities Report & Appendix 4COct 27

All Avecho Biotechnology news releases

Follow Avecho Biotechnology into a list and get an email when it puts out news.

Follow Avecho Biotechnology